Evidence map›Paper›PMID 38696137›Full record

ArticleThe Journal of clinical psychiatry2024

Clozapine Use Among People With Psychotic Disorders Who Experience Specific Indications for Clozapine.

Gregory E Simon, Rebecca C Rossom, Esti Iturralde, Brian K Ahmedani, Stephen C Waring, Ashli A Owen-Smith, Stacy A Sterling, Kathleen Miley, Cheryl D Stults, Yihe G Daida and 5 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of clinical psychiatry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 1 country.

Gregory E SimonKaiser Permanente Washington Health Research Institute, Seattle, Washington.
Rebecca C RossomHealthPartners Institute, Minneapolis, Minnesota.
Esti IturraldeDivision of Research, Kaiser Permanente Northern California, Oakland, California.
Brian K AhmedaniCenter for Health Policy and Health Services Research, Henry Ford Health, Detroit, Michigan.
Stephen C WaringEssentia Institute of Rural Health, Duluth, Minnesota.
Ashli A Owen-SmithGeorgia State University and Kaiser Permanente Georgia, Atlanta, Georgia.
Stacy A SterlingDivision of Research, Kaiser Permanente Northern California, Oakland, California.
Kathleen MileyHealthPartners Institute, Minneapolis, Minnesota.
Cheryl D StultsSutter Health, Palo Alto, California.
Yihe G DaidaCenter for Integrated Health Care Research, Kaiser Permanente Hawaii, Honolulu, Hawaii.
Frances L LynchCenter for Health Research, Kaiser Permanente Northwest, Portland, Oregon.
Arne BeckInstitute for Health Research, Kaiser Permanente Colorado, Denver, Colorado.
Katherine SanchezBaylor Scott & White Research Institute, Dallas, Texas.
Karen J ColemanDepartment of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California.
Susan M ShortreedKaiser Permanente Washington Health Research Institute, Seattle, Washington.
Kaiser Permanente · USHealthPartners · USKaiser Permanente Washington Health Research Institute · USBaylor Medical Center at Garland · USEssentia Health · USHenry Ford Health System · USKaiser Permanente Center for Health Research · USSutter Health · US

Funding

Whose Depression Are We Measuring?: Considering the role of place on Black women’s depression outcomesU19MH121738 · NIMH · KAISER FOUNDATION RESEARCH INSTITUTE · PI SIMON, GREGORY E. · 2019 to 2023
$10.6M
Optimizing Care to Prevent Diabetes and Promote Cardiovascular Health Among Younger Adults with Severe Mental IllnessK23MH126078 · NIMH · KAISER FOUNDATION RESEARCH INSTITUTE · PI Esti Iturralde · 2022 to 2026
$1.0M
NIMH NIH HHS K23 MH126078NIMH NIH HHS U19 MH121738
6 · The paper itself

Abstract

Indexed as

Antipsychotic AgentsClozapinePsychotic DisordersAdolescentAdultFemaleHospitalizationHumansMaleMiddle AgedSchizophreniaSelf-Injurious BehaviorSuicidal IdeationUnited StatesYoung AdultAntipsychotic AgentsClozapine

Identifiers

PMID38696137
PMCPMC11798588
OpenAlexW4396577950

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.